BIOMAT Database Logo BIOMAT Database Logo

Urokinase-induced fibrin clot lysis and its inhibition by plasma. 1980

G Carlin

The kinetics of the urokinase-induced plasmin digestion of fibrin clots has been studied. Some theoretical aspects on the kinetics of the underlying enzyme reactions are presented. It is shown that the clot-lysis time may be used to measure the relative amounts of fibrinolysis inhibitors in plasma.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000933 Antifibrinolytic Agents Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. Antifibrinolysin,Antifibrinolysins,Antifibrinolytic,Antifibrinolytic Agent,Antiplasmin,Antiplasmins,Antifibrinolytics,Plasmin Inhibitor,Plasmin Inhibitors,Agent, Antifibrinolytic,Agents, Antifibrinolytic,Inhibitor, Plasmin,Inhibitors, Plasmin
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator

Related Publications

G Carlin
Some aspects of fibrin clot lysis and its inhibition by human serum.
August 1967, Thrombosis et diathesis haemorrhagica,
G Carlin
Fibrin Clot Formation and Lysis in Plasma.
September 2020, Methods and protocols,
G Carlin
The influence of fibrin crosslinking on the kinetics of urokinase-induced clot lysis.
September 1971, British journal of haematology,
G Carlin
Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activator.
February 1990, Thrombosis research,
G Carlin
Kinetics of fibrin clot lysis.
January 1968, The Biochemical journal,
G Carlin
Herpesviruses enhance fibrin clot lysis.
April 2012, Thrombosis and haemostasis,
G Carlin
Plasma fibrin clot proteomics in healthy subjects: Relation to clot permeability and lysis time.
September 2019, Journal of proteomics,
G Carlin
Weight reduction is associated with increased plasma fibrin clot lysis.
November 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,
G Carlin
Magnetic urokinase: targeting of urokinase to fibrin clot.
April 1988, Biochemical and biophysical research communications,
G Carlin
Tissue transamidases, fibrin stabilization and clot lysis.
December 1972, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!